Sertaconazole nitrate

CAS No. 99592-39-9

Sertaconazole nitrate( FI-7045 )

Catalog No. M16913 CAS No. 99592-39-9

Sertaconazole nitrate is a topical broad-spectrum antifungal that is developed to provide an additional agent for the treatment of superficial cutaneous and mucosal infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 34 In Stock
25MG 43 In Stock
50MG 59 In Stock
100MG 88 In Stock
200MG 170 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sertaconazole nitrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sertaconazole nitrate is a topical broad-spectrum antifungal that is developed to provide an additional agent for the treatment of superficial cutaneous and mucosal infections.
  • Description
    Sertaconazole nitrate is a topical broad-spectrum antifungal that is developed to provide an additional agent for the treatment of superficial cutaneous and mucosal infections.(In Vitro):Sertaconazole nitrate (0.03-40 μg/mL; 24 h) inhibits 150 strains of yeasts which includes six Candida species with arithmetic mean MIC of 0.77 μg/mL.Sertaconazole nitrate (1 μg/mL; 5, 10, 30, 60 min) activates p38 MAP kinase in a time-dependent manner.Sertaconazole nitrate (1, 2 μg/mL; 6, 8, or 24 h) increases a twofold release of PGE2 via COX-2 in keratinocytes, which is dependent on p38 activation.Sertaconazole nitrate (10, 20, 30, 40 μM; 24 h) induces strong mitotic arrest by depolymerizing interphase and spindle microtubules, thereby inducing chromosome aggregation defects and causing anti-proliferation effect.Sertaconazole nitrate (20, 40 μM; 24 h) induces apoptosis through p53 pathway in HeLa cells.Sertaconazole nitrate (20, 30 μM; 24, 48, and 72 h) inhibits the migration of HeLa cells in a concentration-dependent manner.Sertaconazole nitrate (15, 30 μM; 24 h) induces autophagy in A549, H460 cells.(In Vivo):Sertaconazole nitrate (1% (w/v); apply to the left ear, once) suppresses of TPA-induced ear edema CD-1 mice.
  • In Vitro
    Sertaconazole nitrate (0.03-40 μg/mL; 24 h) inhibits 150 strains of yeasts which includes six Candida species with arithmetic mean MIC of 0.77 μg/mL.Sertaconazole nitrate (1 μg/mL; 5, 10, 30, 60 min) activates p38 MAP kinase in a time-dependent manner.Sertaconazole nitrate (1, 2 μg/mL; 6, 8, or 24 h) increases a twofold release of PGE2 via COX-2 in keratinocytes, which is dependent on p38 activation.Sertaconazole nitrate (10, 20, 30, 40 μM; 24 h) induces strong mitotic arrest by depolymerizing interphase and spindle microtubules, thereby inducing chromosome aggregation defects and causing anti-proliferation effect.Sertaconazole nitrate (20, 40 μM; 24 h) induces apoptosis through p53 pathway in HeLa cells.Sertaconazole nitrate (20, 30 μM; 24, 48, and 72 h) inhibits the migration of HeLa cells in a concentration-dependent manner.Sertaconazole nitrate (15, 30 μM; 24 h) induces autophagy in A549, H460 cells.Cell Viability Assay Cell Line:C. albicans, C. guilliermondii, C. krusei, C. parapsilosi, C. tropicalis, C.glabrata Concentration:0.03-40 μg/mL Incubation Time:24 h Result:Againsted 150 strains of yeasts (six Candida species) which included C. albicans, C. guilliermondii, C. krusei, C. parapsilosi, C. tropicalis, C. glabrata species with arithmetic mean MIC values of 1.02, 0.51, 0.38, 0.31, 1.67 and 0.78 μg/mL, respectively.Western Blot Analysis Cell Line:HaCaT cells Concentration:1 μg/mL Incubation Time:5, 10, 30, 60 minResult:Showed activity of activating p38 MAP kinase and Hsp27 in a time-dependent manner.Western Blot Analysis Cell Line:HaCaT cells Concentration:1, 2 μg/mL Incubation Time:6 or 8 h Result:Induced 50% expression of COX-2 and resulted in a twofold increased in PGE2 release.Western Blot Analysis Cell Line:siRNA-transfected HaCaT cells (without p38 MAP kinase expression)Concentration:1 μg/mL Incubation Time:24 h Result:Mediated induction of PGE2 was dependent on p38 activation.Cell Proliferation Assay Cell Line:HeLa, HEK-293, MCF-7, A549 cells Concentration:0-100 μM Incubation Time:24 h Result:Showed antiproliferation activity with IC50s of 38, 45.1, 41.5, and 40.8 μM for HeLa, HEK-293, A549, and MCF-7 cells, respectively.
  • In Vivo
    Sertaconazole nitrate (1% (w/v); apply to the left ear, once) suppresses of TPA-induced ear edema CD-1 mice. Animal Model:CD-1 mice (TPA-induced ear edema model).Dosage:1% (w/v) Administration:Apply to the left ear, once.Result:Exhibited a significant reduction of inflammation in mice by mediating PGE2 release.
  • Synonyms
    FI-7045
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    99592-39-9
  • Formula Weight
    500.78
  • Molecular Formula
    C20H15Cl3N2OS·HNO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (199.68 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    O[N+]([O-])=O.ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liebel F, et al. Arch Dermatol Res, 2006, 298(4), 191-199.
molnova catalog
related products
  • D3-βArr

    D3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.

  • Haloxyfop

    (±)-Haloxyfop is a herbicide.

  • (S)-Lisofylline

    (S)-Lisofylline is the inactive optical enantiomer of (R)-lisofylline which is an anti-inflammatory agent. (S)-Lisofylline is exclusively converted to pentoxifylline in human liver microsomes.